Navigation Links
Singapore First in Southeast Asia to Use Novel Treatment for Sports and Musculoskeletal Injuries
Date:4/14/2009

Originally employed in dentistry, this method of accelerated tissue healing is showing its worth in soft-tissue repair, says one Singapore doctor.

Singapore (PRWEB) April 14, 2009 -- It was first used by dental surgeons about 15 years ago to enhance wound healing of bone grafts during dental reconstructive surgery. Platelet Rich Plasma (PRP) therapy is today being applied in Singapore as an alternative to the conventional mode of treating a wide variety of sports injuries and degenerative conditions in muscles, tendons and joints. The results augur well for professional and weekend sportspersons alike.

"With conventional treatment, a calf muscle tear for instance, would normally take about six weeks to heal. However, with PRP, it would only take half the time. In fact, ultrasonic evidence of healing was apparent as early as seven to 10 days after the injection was administered. Normally, this would have taken between two to three weeks," revealed Dr Patrick Goh, Consultant Sports Physician at SportsMed Central, a clinic that runs under the Healthway Medical Group umbrella.

When injury occurs to musculoskeletal tissues, the body's healing mechanism triggers a blood clot where platelets accumulate. Central to the body's normal healing process, the platelets then release growth factors and signalling molecules (cytokines) to initiate repair. These growth factors attract stem cells to the injured area, stimulate DNA and cell synthesis and promote many activities associated with regeneration and tissue healing.

PRP therapy involves the isolation and concentration (two to six times higher) of the patient's own blood platelets before injecting them into the site of the injury. With a rich environment of vital growth factors created here, the healing process is accelerated.

During the 30-minute minimally-invasive outpatient procedure, about 8 ml of blood is drawn under sterile conditions, processed in a centrifuge before it is injected back into the site of injury. This is usually done under ultrasound guidance to offer maximum accuracy of the injection by a sports physician or orthopaedic surgeon. Local anaesthetic may be applied prior to the PRP injection. The entire process is relatively painless and patients are usually able to walk and perform normal daily activities after the injection.

Besides muscle tears or strains, other conditions which can benefit from PRP therapy include tendon tears or strains, tendon inflammation or degeneration (including tennis elbow and Achilles tendonitis), ligament tears and joint cartilage 'wear and tear' (osteoarthritis).

Singapore became the first country in Southeast Asia to introduce the treatment about a year ago. To date, Dr Goh has treated over 90 patients with PRP at his clinic located at the renowned Gleneagles Medical Centre in Singapore.

As regards to safety, Dr Goh assured, "PRP is low risk since it only involves the injection of the patient's own blood products. There is hence no chance of rejection or acquiring infections such as hepatitis or AIDS. For the doctor, it offers a relatively quick procedure to perform."

Short-term side-effects include soreness and stiffness at the injected site, while over the longer term, mild stiffening and scarring may occur but usually no worse than what is expected with normal healing.

Dr Goh emphasised, "Platelets can also only survive for seven to 10 days, so the "boost" towards regeneration given by the PRP is not ongoing, unlike the potentially more permanent nature of stem cell treatments. However, in many instances, this boost is all that is needed for injuries to heal quicker."

About Healthway Medical Group (www.healthwaymedical.com)
With more than 15 years in the healthcare industry, it is one of the largest integrated healthcare providers based in Singapore. The group offers medical services encompassing primary healthcare, aesthetics, dentistry and specialist medical services which cover a wide range of medical specialties. Staying at the forefront of medical advances, the group prides itself in delivering effective and efficient medical care with a personal touch.    

About SingaporeMedicine (www.singaporemedicine.com)
Launched in 2003, SingaporeMedicine is a multi-agency government-industry partnership committed to strengthening Singapore's position as Asia's leading medical hub and international health care destination. Led by the Ministry of Health of Singapore, SingaporeMedicine is supported by three government agencies: the Economic Development Board, which develops industry capabilities, the International Enterprise Singapore, which fosters regionalism by Singapore-based health care players, and the Singapore Tourism Board, which markets Singapore as a healthcare destination to inbound international patients and develops associated people-oriented services.

###

Read the full story at http://www.prweb.com/releases/singapore-medicine/asia-leading-medical-hub/prweb2315934.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. SingaporeMedicine Highlights Singapore's Advanced Pain Management Techniques
2. Singapore Gives New Sight to the Blind
3. Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids
4. Singapore Offers Grants to Research Scientists to Start Labs Here
5. Abbott Opens New Pediatric Nutrition Manufacturing Facility in Singapore
6. Hospital Build Asia Exhibition and Congress 2009: Regions Most Comprehensive Healthcare Infrastructure Planning and Development Event to Debut in Singapore
7. Nanyang Technological University launches first-ever sports degree in Singapore
8. Abbott Opens New Pharmaceutical Research Laboratory in Singapore
9. Abbott Nutrition Announces Voluntary Recall of ZonePerfect(R) Chocolate Peanut Butter Bars, ZonePerfect(R) Peanut Toffee Bars and NutriPals(TM) Peanut Butter Chocolate Bars in U.S., Mexico, New Zealand and Singapore
10. STEMCELL Technologies Launches Direct Distribution to Singapore
11. Singapore is First in Asia to Use Limb-lengthening Technology for Those Wanting to be Taller
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Singapore First in Southeast Asia to Use Novel Treatment for Sports and Musculoskeletal Injuries
(Date:12/7/2016)... ... 07, 2016 , ... They are musicians and librarians, fashion designers and fitness ... from New England and around the nation. What do they have in common? All ... a beautiful and compelling new photographic exhibit debuting Friday, December 9 at Logan International ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... and financial consultation services to residents in the Sacramento/Folsom region, is initiating a ... treatment facility. , The Another Choice Another Chance treatment center in Sacramento works ...
(Date:12/7/2016)... ... ... A. Kevin Spann Insurance, a New York-based firm offering insurance and financial consultation ... drive to raise funds that will benefit the Marine Corps League. , The Marine ... Corpsmen. Working closely with the MCL, the A. Kevin Spann team plans to generate ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
(Date:12/7/2016)... ... 2016 , ... The medical profession is well aware that heart attacks do ... analyzing heart attacks among 138,602 people recorded a 35% higher number of heart attacks ... agree of course–no time of year is a good time for a heart attack! ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016 Anaplastic Oligoastrocytoma - ... Markets Direct,s latest Pharmaceutical and Healthcare disease pipeline ... provides an overview of the Anaplastic Oligoastrocytoma (Oncology) ... tumor that forms when two types of cells ... increase in number to form a mass. These ...
(Date:12/6/2016)... 2016  Nearly 30 million people in ... of diabetes. 1 However, nearly 40% of diabetes ... (hyperglycemia) and significant glucose variability. 2 These patients are ... events. If left untreated, hyperglycemia can lead to cardiovascular ... blindness. 3 As part of Diabetes ...
(Date:12/6/2016)... 2016  Arcturus Therapeutics, Inc. ("Arcturus" or the ... that it entered into collaboration with Takeda Pharmaceutical ... treatment of NASH and other gastrointestinal (GI) related ... and UNA Oligomer chemistry. The financial terms were ... to and expertise in GI disorders, we are ...
Breaking Medicine Technology: